# Fenofibrate

## Lipanthyl 160mg

| TAH Drug Code      | [OLIPS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLIPS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypercholesterolaemia, hypertriglyceridaemia & mixed dyslipidaemias (types IIa, IIb, III, IV, & V).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Adults: one 160mg tablet daily, taken with a main meal. Monitoring treatment response through blood lipid measurements is recommended. If there's inadequate response after a few months (e.g., 3 months), consider supplementation or an alternative treatment.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Children. Pregnant & breastfeeding women. Severe liver dysfunction, including unexplained persistent liver function abnormalities; patients with active liver disease, including primary biliary cirrhosis. Gallbladder disease. Severe chronic kidney disease, including end-stage renal disease or those receiving dialysis. Chronic or acute pancreatitis (except for acute pancreatitis caused by severe hypertriglyceridemia). Hypersensitivity to fibrates or ketoprofen, especially if there's a history of photosensitivity or phototoxic reactions. Hypersensitivity to fenofibrate or its excipients. Hypersensitivity to peanuts, peanut oil, or legume phospholipids. |
| Adverse Effects    | Common: Abdominal pain (4.6%), Nausea (2.3%), Aspartate aminotransferase serum level above reference range (3.4%), Liver function tests outside reference range (7.5%; 3x ULN or greater, 13% with fenofibrate 87-130 mg, 0% with fenofibrate 43 mg or less), Backache (3.4%), Rhinitis (2.3%) Serious: Stevens-Johnson syndrome, Toxic epidermal necrolysis due to drug, Pancreatitis, Cholestatic hepatitis, Injury of liver, drug-induced, Anaphylaxis, Drug reaction with eosinophilia and systemic symptoms, Hypersensitivity reaction, Acute, Delayed hypersensitivity reaction, Rhabdomyolysis Serum creatinine above reference range (12-27%), Angioedema                 |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/fenofibrate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

